Skip to main content
Veterinary Medicines

HIPRAVIAR-SHS

Authorised
  • Turkey rhinotracheitis virus, strain 1062, Live

Product identification

Medicine name:
HIPRAVIAR-SHS
Active substance:
  • Turkey rhinotracheitis virus, strain 1062, Live
Target species:
  • Chicken (broiler)
  • Turkey (for meat production)
  • Chicken (pullet for egg production, future layer)
  • Future breeder pullet
Route of administration:
  • Oculonasal use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain 1062, Live
    44.00
    cell culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Turkey (for meat production)
      • Meat and offal
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
    • Future breeder pullet
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CD01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 2238 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/12/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/12/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/12/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."